Trials / Completed
CompletedNCT01677026
Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Autonomic Technologies, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objectives of the Registry are to: 1. Monitor the transfer of the ATI Neurostimulation System and its safety/clinical performance to a larger number of centers in the post market phase and 2. Collect additional evidence to support reimbursement and clinical acceptance and long term follow up
Conditions
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2018-04-09
- Completion
- 2018-04-09
- First posted
- 2012-08-31
- Last updated
- 2018-06-26
Locations
11 sites across 2 countries: Denmark, Germany
Source: ClinicalTrials.gov record NCT01677026. Inclusion in this directory is not an endorsement.